GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (NAS:TLRY) » Definitions » Market Cap

TLRY (Tilray Brands) Market Cap : $554.1 Mil (As of Jul. 04, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Tilray Brands Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Tilray Brands's share price for the quarter that ended in Feb. 2025 was $0.735. Tilray Brands's Shares Outstanding (EOP) for the quarter that ended in Feb. 2025 was 973.8 Mil. Therefore, Tilray Brands's market cap for the quarter that ended in Feb. 2025 was $715.7 Mil.

Tilray Brands's quarterly market cap declined from Aug. 2024 ($1,497.0 Mil) to Nov. 2024 ($1,240.3 Mil) and declined from Nov. 2024 ($1,240.3 Mil) to Feb. 2025 ($715.7 Mil).

Tilray Brands's annual market cap declined from May. 2022 ($2,391.7 Mil) to May. 2023 ($1,096.6 Mil) but then increased from May. 2023 ($1,096.6 Mil) to May. 2024 ($1,497.5 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Tilray Brands's Enterprise Value for Today is $621.9 Mil.


Tilray Brands Market Cap Historical Data

The historical data trend for Tilray Brands's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Market Cap Chart

Tilray Brands Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,211.98 7,442.17 2,391.71 1,096.61 1,497.47

Tilray Brands Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,339.07 1,497.47 1,497.01 1,240.27 715.71

Competitive Comparison of Tilray Brands's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Market Cap distribution charts can be found below:

* The bar in red indicates where Tilray Brands's Market Cap falls into.


;
;

Tilray Brands Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Tilray Brands's Market Cap for the fiscal year that ended in May. 2024 is calculated as

Market Cap (A: May. 2024 )=Share Price (A: May. 2024 )*Shares Outstanding (EOP) (A: May. 2024 )
=$1.8*831.925
=$1,497.5

Tilray Brands's Market Cap for the quarter that ended in Feb. 2025 is calculated as

Market Cap (Q: Feb. 2025 )=Share Price (Q: Feb. 2025 )*Shares Outstanding (EOP) (Q: Feb. 2025 )
=$0.735*973.753
=$715.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tilray Brands  (NAS:TLRY) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Tilray Brands Market Cap Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands Business Description

Traded in Other Exchanges
Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
Executives
Carl A Merton officer: Chief Financial Officer C/O TILRAY, INC., 745 FIFTH AVENUE, SUITE 1602, NEW YORK NY 10151
Denise M Faltischek officer: Chief Strategy Officer C/O THE HAIN CELESTIAL GROUP, INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Mitchell Gendel officer: Global General Counsel EMERALD HOLDING, INC., 100 BROADWAY, 14TH FLOOR, NEW YORK NY 10005
Irwin D Simon director, officer: President & CEO C/O THE HAIN CELESTIAL GROUP INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Brendan Kennedy director 1920 EASTLAKE AVENUE E., SEATTLE WA 98105
James R. Meiers officer: Head of Canada C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David G. Hopkinson director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Thomas P. Looney director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Johann Michael Herhalt director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Jodi L. Butts director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David F Clanachan director TIM HORTONS INC., 874 SINCLAIR ROAD, OAKVILLE A6 L6K 2Y1
Renah Persofsky director 55 PRINCE ARTHUR AVENUE, #604, TORONTO A6 M5R 1B3
Jon Edward Levin officer: Chief Operating Officer 2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Michael C. Kruteck officer: Chief Financial Officer 2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Rebekah Dopp director 444 LENOX AVENUE, SOUTH ORANGE NJ 07079